申请人:ARROW THERAPEUTICS LTD
公开号:WO2004069998A2
公开(公告)日:2004-08-19
Use of an oxindole derivative of formula (I), or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for use in treating or preventing infection by an organism in which the biosynthesis of aromatic amino acids is effected via the shikimate pathway.